Vision X
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $114M
Investors
- 10
About Vision X
Established in 2019 and based in Zhuhai, China, Vision X is a medical technology company that engaged in ophthalmic medical device development and production, providing eye care products and eye optometry equipment. The company's business covers juvenile myopia prevention and control, adult vision correction and ocular surface disease treatment, optometry diagnosis and treatment equipment, nursing products and other consumer products. The company's RGP product of rigid corneal contact lens "Aikangfei" has been put on the market in 2021.
Who invested in Vision X
10 investors across 2 rounds
See all investors in Vision X
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vision X
Who invested in Vision X?
Vision X has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vision X raised?
Vision X has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vision X last raise money?
Vision X's most recent round on record is a Series B, in Sep 2021.
What does Vision X do?
Established in 2019 and based in Zhuhai, China, Vision X is a medical technology company that engaged in ophthalmic medical device development and production, providing eye care products and eye optometry equipment.
Where is Vision X headquartered?
Vision X is headquartered in Zhuhai, China.
Which VCs invest in companies like Vision X?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Vision X's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Vision X? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.